PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2148907
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2148907
The global animal health market size was valued at USD 70.16 billion in 2025 and is projected to grow from USD 78.27 billion in 2026 to USD 187.79 billion by 2034, registering a CAGR of 11.56% during 2026-2034. North America dominated the global market with a 34.02% market share in 2025. The market includes pharmaceuticals, vaccines, diagnostics, medicated animal feeds, and nutritional products used to prevent, diagnose, and treat diseases in livestock and companion animals.
The increasing importance of veterinary healthcare in food security, zoonotic disease prevention, livestock productivity, and companion animal wellness is supporting market growth. North America generated USD 14.12 billion in revenue in 2025, maintaining its leading position.
Market Trends
The animal health market trends are increasingly centered on preventive healthcare, advanced diagnostics, digital monitoring, and companion animal wellness. Growing pet adoption and the shift from pet ownership toward pet parenthood are encouraging spending on preventive care, chronic disease management, diagnostics, and premium therapeutics.
Digitalization is also transforming veterinary healthcare through remote monitoring, practice-management software, data analytics, and connected health devices. Public-private partnerships are improving veterinary service availability and supporting disease prevention programs. Sustainability is encouraging manufacturers to develop biologics, immunomodulators, functional feed additives, and alternatives to traditional antimicrobials.
Market Drivers
Rising Incidence of Zoonotic Diseases:
Increasing awareness of animal-borne diseases is encouraging governments, farmers, veterinarians, and pet owners to adopt preventive healthcare solutions. Stronger disease surveillance and food-safety requirements are supporting demand for vaccines, diagnostics, and therapeutics.
Growing Demand for Animal-Derived Protein:
Rising global protein consumption is encouraging livestock producers to improve animal productivity and reduce disease-related losses. Preventive vaccination, parasite control, herd diagnostics, and nutritional solutions are becoming important components of modern livestock management.
Increasing R&D Activities:
Continuous research in veterinary medicine is supporting the development of advanced drugs, vaccines, diagnostics, and nutritional products. Innovations in biologics, molecular diagnostics, and precision healthcare are creating additional market opportunities.
Market Restraints and Challenges
Stringent Regulatory Requirements:
The lengthy and expensive approval process for animal drugs and vaccines remains a major market restraint. Development of new veterinary products can require substantial investment and several years of research and regulatory validation.
Additional challenges include antimicrobial-use restrictions, high product-development costs, uneven veterinary infrastructure, limited access to trained professionals in emerging markets, livestock producer cost sensitivity, and limited awareness of preventive healthcare in certain regions.
By Product: The market is segmented into drugs, vaccines, feed, and diagnostics. Drugs represented the largest segment with a 45.5% share in 2025, supported by demand for treatments against infectious diseases, parasites, and chronic conditions. Vaccines and diagnostics are gaining importance as preventive and precision healthcare adoption increases.
By Animal: The market includes livestock animals and companion animals. Companion animals held the largest share in 2025, supported by increasing pet adoption, pet humanization, and growing spending on advanced veterinary care. Livestock remains important because of disease-control and food-production requirements.
By End User: Key end users include veterinary hospitals and clinics, animal care and rehabilitation centers, diagnostic centers, and others. Veterinary hospitals and clinics maintain a leading position, while diagnostic centers are expanding with increased adoption of molecular testing and preventive healthcare.
Regional Analysis
North America led the global market with a 34.02% share in 2025, supported by advanced veterinary infrastructure, strong R&D, high companion animal spending, and large-scale livestock operations.
Europe held the second-largest position, supported by stringent animal health regulations, preventive healthcare adoption, and food-safety requirements.
Asia Pacific is expected to witness healthy growth due to expanding livestock populations, rising protein consumption, increasing pet ownership, and improving veterinary infrastructure. Japan benefits from advanced veterinary care and increasing demand for chronic disease management, while China is experiencing increasing demand linked to livestock modernization and urban companion animal healthcare.
Latin America and the Middle East & Africa are also expected to provide opportunities as veterinary infrastructure, disease-control programs, and technology adoption improve.
Key Industry Players
Major companies operating in the animal health market include Zoetis, Intervet International B.V., Elanco, Ceva, Virbac, Merck & Co., Inc., Novartis AG, Emergent BioSolutions, CSL Limited, IDEXX Laboratories, Bayer AG, and Boehringer Ingelheim International GmbH.
Recent Industry Developments
Recent industry developments include expansion of companion animal biologics, strategic acquisitions in veterinary diagnostics, advanced livestock vaccines, digital herd-health monitoring solutions, and innovative parasiticide formulations. These developments demonstrate the industry's increasing focus on preventive care, diagnostics, digitalization, and specialized therapies.
Future Outlook
The animal health market outlook remains positive through 2034. The market is projected to increase from USD 70.16 billion in 2025 to USD 78.27 billion in 2026 and USD 187.79 billion by 2034. IoT-enabled monitoring, connected veterinary devices, precision diagnostics, advanced biologics, preventive vaccination, and public-private partnerships are expected to reshape the industry.
Conclusion
The global animal health market is experiencing strong expansion as livestock producers and companion animal owners increasingly prioritize disease prevention, early diagnosis, and advanced treatment. Rising zoonotic disease concerns, protein consumption, pet humanization, technological innovation, and veterinary R&D are creating sustained market opportunities. Although regulatory requirements, development costs, antimicrobial restrictions, and infrastructure gaps remain challenges, continued innovation and improved healthcare accessibility are expected to support substantial market growth through 2034.
Unit Value (USD Billion)
Segmentation By Product
By Animal
By End-user
By Geography